Latest filing published 11 Sept 2026 for Gilead Sciences, INC..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Dietmar Berger: trading record in brief
Dietmar Berger is a declared insider at 2 companies; the most frequent names are Gilead Sciences, Inc. and Atara Biotherapeutics, Inc. Between 7 May 2018 and 10 September 2026, the trades on record add up to 13 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 11 September 2026 came the latest disclosure, an option exercise in Gilead Sciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Dietmar Berger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 533 sharesCommon StockSEC:0001739515-26-000011:0
- 263 shares@ US$144.81Common StockSEC:0001739515-26-000011:1
- 533 sharesCommon StockSEC:0001739515-26-000008:0
- 263 sharesCommon StockSEC:0001739515-26-000008:1
- 2,133 sharesCommon StockSEC:0001739515-26-000006:0
- 8,530 shares0Common StockSEC:0001739515-26-000004:0
- 16,326 sharesCommon StockSEC:0001739515-26-000002:0
7 of 7 declarations
